Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Surgery
NCT07643792Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Aug 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Area Under Curve of Pain Intensity at 72 hours. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07643792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07643792.